Detalhe da pesquisa
1.
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
PLoS Pathog
; 19(4): e1011298, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075079
2.
Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.
Mol Ther
; 31(2): 387-397, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184852
3.
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
J Antimicrob Chemother
; 76(2): 413-417, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164048
4.
A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever.
NPJ Vaccines
; 9(1): 86, 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769294
5.
Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice.
EBioMedicine
; 101: 105017, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382314
6.
CD8+ T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice.
EBioMedicine
; 97: 104839, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866114
7.
Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
EBioMedicine
; 82: 104188, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907368
8.
Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2.
Microorganisms
; 10(2)2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35208863
9.
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Elife
; 112022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191378
10.
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
EBioMedicine
; 83: 104196, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932641
11.
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
bioRxiv
; 2022 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982677
12.
A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins.
Viruses
; 13(2)2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670641
13.
An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters.
Microorganisms
; 9(5)2021 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34065996
14.
Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
Elife
; 102021 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416494
15.
T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice.
Microorganisms
; 9(2)2021 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33572859
16.
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.
bioRxiv
; 2021 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931189
17.
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.
Nat Commun
; 12(1): 2295, 2021 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33863887
18.
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers.
bioRxiv
; 2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024974
19.
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.
Res Sq
; 2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33052329
20.
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.
JCI Insight
; 5(23)2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090972